Gaurav Chandra
Director/Board Member bij ENZOLYTICS, INC.
Profiel
Gaurav Chandra is currently the Chief Executive Officer at Biogenysis, Inc., the Director at Enzolytics, Inc. starting in 2024, and the Chief Operating Officer at Bioclonetics Immunotherapeutics, Inc. In terms of education, Dr. Chandra holds a doctorate degree from Albert Einstein College of Medicine, Inc., an undergraduate degree from Kasturba Medical College, and an MBA from the University of Colorado Denver.
Actieve functies van Gaurav Chandra
Bedrijven | Functie | Begin |
---|---|---|
ENZOLYTICS, INC. | Director/Board Member | - |
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Chief Operating Officer | - |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Chief Executive Officer | - |
Opleiding van Gaurav Chandra
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Kasturba Medical College | Undergraduate Degree |
University of Colorado Denver | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ENZOLYTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Bioclonetics Immunotherapeutics, Inc.
Bioclonetics Immunotherapeutics, Inc. BiotechnologyHealth Technology Bioclonetics Immunotherapeutics, Inc. is a biotechnology company. It produces human IgG1 mono clinical antibodies for treating infectious diseases with non toxic passive immunotherapy. The company was founded by Joseph Cotropia and is headquartered in Heath, TX. | Health Technology |
Biogenysis, Inc.
Biogenysis, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Enzolytics, Inc., Biogenysis, Inc. engages in the research and development of species specific monoclonal antibodies against diseases. The private company is based in Dallas, TX. The CEO of the company is Gaurav Chandra. | Commercial Services |